pp32 (ANP32A) Expression Inhibits Pancreatic Cancer Cell Growth and Induces Gemcitabine Resistance by Disrupting HuR Binding to mRNAs-Reference-Cited by-同舟云学术

pp32 (ANP32A) Expression Inhibits Pancreatic Cancer Cell Growth and Induces Gemcitabine Resistance by Disrupting HuR Binding to mRNAs

Published:2010-11-29 Issue:11 Volume:5 Page:e15455
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Williams Timothy K.,Costantino Christina L.,Bildzukewicz Nikolai A.,Richards Nathan G.,Rittenhouse David W.,Einstein Lisa,Cozzitorto Joseph A.,Keen Judith C.,Dasgupta Abhijit,Gorospe Myriam,Gonye Gregory E.,Yeo Charles J.,Witkiewicz Agnieszka K.,Brody Jonathan R.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Survival and prognostic factors of unresectable pancreatic cancer.;JK Park;J Clin Gastroenterol,2008

2. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.;CJ Yeo;Ann Surg,1997

3. Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer.;JK Park;Pancreas,2006

4. Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine.;A Sawaki;J Gastroenterol Hepatol,2008

5. Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors.;C Sezgin;Scand J Gastroenterol,2005

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the RNA-Binding Protein HuR in Cancer;Cancer Research;2023-09-08

2. Relationship between HuR and tumor drug resistance;Clinical and Translational Oncology;2023-03-22

3. Characteristic gene prognostic model of type 1 diabetes mellitus <i>via</i> machine learning strategy;Endocrine Journal;2023

4. Anp32a Promotes Neuronal Regeneration after Spinal Cord Injury of Zebrafish Embryos;International Journal of Molecular Sciences;2022-12-14

5. ANP32 Family as Diagnostic, Prognostic, and Therapeutic Biomarker Related to Immune Infiltrates in Hepatocellular Carcinoma;Disease Markers;2022-03-03